Endometrial cancer is cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Endometrium Tumor Cells, Cultured Neoplastic Stem Cells Breast Prostate Lymph Nodes Myometrium HCT116 Cells MCF-7 Cells

Organisms2

Mice, Nude Mice, SCID

Diseases55

Endometrial Neoplasms Carcinoma, Endometrioid Ovarian Neoplasms Breast Neoplasms Neoplasm Invasiveness Endometrial Hyperplasia Prostatic Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Genetic Predisposition to Disease Neoplasms Uterine Neoplasms Carcinoma Adenocarcinoma Pancreatic Neoplasms Cystadenocarcinoma, Serous Uterine Cervical Neoplasms Genital Neoplasms, Female Colorectal Neoplasms, Hereditary Nonpolyposis Neoplasm Recurrence, Local Disease Progression Colorectal Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms, Hormone-Dependent Cystadenocarcinoma, Papillary Cell Transformation, Neoplastic Rectal Neoplasms Neoplasms, Second Primary Precancerous Conditions Neoplasms, Multiple Primary Esophageal Neoplasms Microsatellite Instability Neovascularization, Pathologic Mixed Tumor, Mullerian Head and Neck Neoplasms Liver Neoplasms Mouth Neoplasms Carcinoma, Small Cell Neoplasms, Radiation-Induced Bone Neoplasms Neoplasms, Glandular and Epithelial Uterine Hemorrhage Obesity Skin Neoplasms Carcinoma, Adenosquamous Gastrointestinal Neoplasms Adenocarcinoma, Papillary Thyroid Neoplasms Mixed Tumor, Mesodermal Peritoneal Neoplasms

Chemicals and Drugs57

Tamoxifen Neoplasm Proteins Tumor Markers, Biological Receptors, Estrogen Estrogens Cancer Vaccines Receptors, Progesterone Antineoplastic Agents, Hormonal Antineoplastic Agents RNA, Messenger DNA, Neoplasm Progestins Receptor, erbB-2 RNA, Small Interfering Estrogen Antagonists Tumor Suppressor Protein p53 PTEN Phosphohydrolase Estrogen Receptor alpha Paclitaxel Prostate-Specific Antigen Tumor Suppressor Proteins Cisplatin Contraceptives, Oral Anticarcinogenic Agents Antigens, Neoplasm Antineoplastic Agents, Phytogenic Estrogen Receptor Modulators MicroRNAs Fluorouracil Nuclear Proteins DNA-Binding Proteins Selective Estrogen Receptor Modulators Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins Receptor, Epidermal Growth Factor Antibodies, Monoclonal Adaptor Proteins, Signal Transducing RNA, Neoplasm MutS Homolog 2 Protein Receptors, Androgen Estradiol Transcription Factors CA-125 Antigen TOR Serine-Threonine Kinases Deoxycytidine Androgens Antimetabolites, Antineoplastic Aromatase Inhibitors Toremifene Taxoids Cadherins Protein Kinase Inhibitors Nitriles Phosphatidylinositol 3-Kinases Raloxifene BRCA2 Protein Phytoestrogens

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Early Detection of Cancer Neoplasm Staging Prognosis Risk Risk Factors Hysterectomy Survival Rate Survival Analysis Odds Ratio Prospective Studies Retrospective Studies Reverse Transcriptase Polymerase Chain Reaction Follow-Up Studies Registries Risk Assessment Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Gene Expression Profiling Xenograft Model Antitumor Assays Disease-Free Survival Blotting, Western Estrogen Replacement Therapy Incidence Chemotherapy, Adjuvant SEER Program Neoplasm Grading Sensitivity and Specificity Immunohistochemistry Kaplan-Meier Estimate Logistic Models Neoplasm Transplantation Multivariate Analysis Combined Modality Therapy Oligonucleotide Array Sequence Analysis Questionnaires Lymph Node Excision Salpingectomy Cohort Studies Transplantation, Heterologous Confidence Intervals Molecular Targeted Therapy Polymerase Chain Reaction Drug Screening Assays, Antitumor Body Mass Index Tumor Burden Clinical Trials as Topic Radiotherapy, Adjuvant Tissue Array Analysis Immunoenzyme Techniques Predictive Value of Tests Hormone Replacement Therapy Mammography Transfection Treatment Outcome Reproducibility of Results Radiotherapy Genetic Testing Gene Knockdown Techniques Models, Biological DNA Mutational Analysis Flow Cytometry Drug Administration Schedule Biopsy Obesity Gynecologic Surgical Procedures Real-Time Polymerase Chain Reaction Reproductive History

Psychiatry and Psychology1

Phenomena and Processes52

Gene Expression Regulation, Neoplastic Risk Genetic Predisposition to Disease Postmenopause Odds Ratio Mutation Drug Resistance, Neoplasm DNA Methylation Genotype Germ-Line Mutation Cell Proliferation Sensitivity and Specificity Polymorphism, Genetic Cell Growth Processes Apoptosis Cell Survival Gene Silencing Down-Regulation Menopause Cell Cycle Cell Division Cell Movement Body Mass Index Premenopause Promoter Regions, Genetic Microsatellite Instability Dose-Response Relationship, Drug Genes, Tumor Suppressor Microsatellite Repeats Diet Genes, BRCA1 Transfection RNA Interference Signal Transduction Up-Regulation Parity Genes, Neoplasm Base Sequence Alleles Gene Expression Genes, p53 Epithelial-Mesenchymal Transition Phosphorylation Phenotype Obesity DNA Mismatch Repair Drug Synergism CpG Islands Genes, erbB-2 DNA Repair Genes, BRCA2 Time Factors

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena4

National Cancer Institute (U.S.)Quality of Life Age Distribution Survival

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care34

Risk Risk Factors Survival Rate Survival Analysis Odds Ratio Prospective Studies Retrospective Studies Follow-Up Studies Registries Risk Assessment Case-Control Studies Disease-Free Survival Age Factors National Cancer Institute (U.S.)Incidence SEER Program Sensitivity and Specificity Kaplan-Meier Estimate Logistic Models Multivariate Analysis Questionnaires Cohort Studies Confidence Intervals Body Mass Index Clinical Trials as Topic Predictive Value of Tests Treatment Outcome Reproducibility of Results Parity Genetic Testing American Cancer Society Confounding Factors (Epidemiology)Age Distribution Reproductive History

Geographicals4

United States China Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Endometrial Neoplasms Carcinoma, Endometrioid Early Detection of Cancer Ovarian Neoplasms Breast Neoplasms Neoplasm Invasiveness Endometrial Hyperplasia Prostatic Neoplasms Gene Expression Regulation, Neoplastic Neoplasm Staging Lung Neoplasms Prognosis Stomach Neoplasms Risk Colonic Neoplasms Neoplasm Metastasis Risk Factors Genetic Predisposition to Disease Cell Line, Tumor Hysterectomy Tamoxifen Neoplasms Uterine Neoplasms Mice, Nude Endometrium Carcinoma Neoplasm Proteins Tumor Markers, Biological Survival Rate Survival Analysis Adenocarcinoma Pancreatic Neoplasms Receptors, Estrogen Postmenopause Cystadenocarcinoma, Serous Uterine Cervical Neoplasms Genital Neoplasms, Female Estrogens Odds Ratio Prospective Studies Cancer Vaccines Receptors, Progesterone Retrospective Studies Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Agents, Hormonal Follow-Up Studies Antineoplastic Agents Registries Risk Assessment Colorectal Neoplasms, Hereditary Nonpolyposis United States Neoplasm Recurrence, Local Antineoplastic Combined Chemotherapy Protocols RNA, Messenger Mutation Disease Progression Drug Resistance, Neoplasm Case-Control Studies Colorectal Neoplasms Gene Expression Profiling Xenograft Model Antitumor Assays DNA Methylation Disease-Free Survival Carcinoma, Squamous Cell Age Factors Genotype Adenocarcinoma, Clear Cell Blotting, Western Estrogen Replacement Therapy DNA, Neoplasm Progestins Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung National Cancer Institute (U.S.)Neoplasms, Hormone-Dependent Receptor, erbB-2 Incidence RNA, Small Interfering Survivors Germ-Line Mutation Cell Proliferation Chemotherapy, Adjuvant Cystadenocarcinoma, Papillary SEER Program Cell Transformation, Neoplastic Neoplasm Grading Sensitivity and Specificity Immunohistochemistry Kaplan-Meier Estimate Logistic Models Polymorphism, Genetic Neoplasm Transplantation Multivariate Analysis Cell Growth Processes Estrogen Antagonists Combined Modality Therapy Apoptosis Tumor Suppressor Protein p53 Rectal Neoplasms Oligonucleotide Array Sequence Analysis

No FAQ available that match "endometrial cancer is cancer"